Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Net Margin (2022 - 2025)

Historic Net Margin for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Q1 2025 value amounting to 174.23%.

  • Centessa Pharmaceuticals' Net Margin changed N/A to 174.23% in Q1 2025 from the same period last year, while for Sep 2025 it was 1617.99%, marking a year-over-year decrease of 78928900.0%. This contributed to the annual value of 2204.65% for FY2023, which is N/A changed from last year.
  • Per Centessa Pharmaceuticals' latest filing, its Net Margin stood at 174.23% for Q1 2025.
  • In the past 5 years, Centessa Pharmaceuticals' Net Margin registered a high of 3911.74% during Q2 2022, and its lowest value of 174.23% during Q1 2025.
  • Over the past 3 years, Centessa Pharmaceuticals' median Net Margin value was 1959.74% (recorded in 2022), while the average stood at 2029.58%.
  • The largest annual percentage gain for Centessa Pharmaceuticals' Net Margin in the last 5 years was -5263900bps (2023), contrasted with its biggest fall of -28959800bps (2023).
  • Centessa Pharmaceuticals' Net Margin (Quarter) stood at 1959.74% in 2022, then dropped by -27bps to 1433.35% in 2023, then crashed by -112bps to 174.23% in 2025.
  • Its last three reported values are 174.23% in Q1 2025, 1433.35% for Q4 2023, and 1520.98% during Q3 2023.